Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) Debt to equity

Alert me on Debt to equity

Eli Lilly and Company's debt to equity at the end of the quarter to 30 June 2026 was 1.6×, up 0.1× from fiscal 2025 (1.5×). Over the past ten years it has ranged from 0.5× (fiscal 2015) to 5.7× (fiscal 2019); the current reading is higher than 55% of that period. That is above the Drug Manufacturers General industry median of 0.6× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 1.5× (22.94%)
FY2024 2.0× 18.52%
FY2023 1.7× 23.30%
FY2022 1.4× (18.41%)
FY2021 1.7× (41.16%)
FY2020 2.8× (50.19%)
FY2019 5.7× 505.93%
FY2018 0.9× (19.30%)
FY2017 1.2× 59.84%
FY2016 0.7× 33.93%

Quarterly newest first

Period Debt to equity Change
Jun 2026 1.6× 28.43%
Mar 2026 1.3× (21.22%)
Dec 2025 1.6× (6.53%)
Sep 2025 1.7× (21.20%)
42 more quarters

Against its own ten years

Low 0.5× High 5.7×
Ten-year median 1.5×
Current reading's percentile 55

Debt to equity against peers

Company Debt to equity
ABBV AbbVie Inc. compare −12.0×
JNJ Johnson & Johnson compare 0.4×
AZN AstraZeneca PLC compare 0.6×
PFE Pfizer Inc. compare 0.7×
NVS Novartis AG compare 1.1×
MRK Merck & Co., Inc. compare 1.2×
LLY Eli Lilly and Company 1.6×
GILD Gilead Sciences, Inc. compare 2.2×
AMGN Amgen Inc. compare 4.9×
Drug Manufacturers General industry median 0.6×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on LLY